When incubated with patulin, certain microorganisms including Saccharomyces cerevisiae (Moss and Long, 2002), Kodameae ohmeri (Dong et al., 2015), Gluconobacter oxydans (Ricelli et al., 2007), and Sporobolomyces accumulate E-and/or Z-ascladiol (Ianiri et al., 2013)
This formulation is indicated for the treatment of cobalamin deficiency states, including pernicious anemia, and for the treatment of cyanide poisoning
, 3 15mg 2b
Try Targeted Therapies Technologies like Osteoboosts precision vibration therapy provide mechanical stimulation to the bones, helping maintain strength in key areas like the hips and spine
stability data for the combined solution do not currently exist
Research Frontier New & Potential Future Treatments The relationship between GLP-1 medications and hair is an active area of dermatologic research, and the picture is more nuanced than "GLP-1 causes hair loss." Interestingly, several case reports have also described hair regrowth or stabilization in patients on GLP-1 therapy, particularly when hair loss was originally driven by insulin resistance or metabolic dysfunction, since improved glycemic control can, in some patients, benefit certain hair loss subtypes such as central centrifugal cicatricial alopecia (CCCA) and androgenetic alopecia
